Showing 201-210 of 1308 results for "".
A Dose of Cultural Guidance With a Side of Dry Eye
https://modernod.com/podcasts/the-mod-pod/a-dose-of-cultural-guidance-with-a-side-of-dry-eye/36857/Check out this month's episode of The MOD Pod, where host Cecelia Koetting, OD, FAAO, Dipl ABO, chats with Bryce St. Clair, OD, about the importance of providing empathetic, patient-centered care across diverse communities. The two discuss how to learn about patient culture or religion without seemiHealth Equity • Glaucoma + Cataract • Bacterial Conj Masqueraders
https://modernod.com/podcasts/the-mod-pod/health-equity-glaucoma-cataract-bacterial-conj-masqueraders/36837/Check out this great episode of The MOD Pod! Lori Latowski Grover, OD, PhD, kicks things off with an overview of the current state of health equity because access to quality health care is still not a guarantee for all (00:55). Justin Schweitzer, OD, FAAO, follows with some considerations to keep in[Genetics and Eyecare Today] How CXL and Genetic Testing Fit Into the Keratoconus Game Plan
https://modernod.com/podcasts/the-mod-pod/genetics-and-eyecare-today-how-cxl-and-genetic-testing-fit-into-the-keratoconus-game-plan/36816/The season finale of The MOD Pod’s mini series Genetics and Eyecare Today features Nicole Fram, MD, and Melissa Barnett, OD, FAAO, FSLS, FBCLA. Dr. Fram explains what corneal collagen crosslinking is and shares her protocol for administering the therapy. She also describes the typical situation in wA Decade of Developments in Glaucoma Management
https://modernod.com/videos/eye-care-insiders/a-decade-of-development-in-glaucoma-management/37354/Joseph J. Allen, OD, FAAO, Dipl ABO, highlights some of the biggest game-changers in glaucoma management from the past decade, from microinvasive glaucoma surgery to new therapeutics to the acceptance of selective laser trabeculoplasty as a primary therapeutic option for glaucoma.How to (Respectfully) Correct a Patient
https://modernod.com/videos/eye-care-insiders/eci-video-january-2025/37352/Joseph J. Allen, OD, FAAO, Dipl ABO, offers some best practices on an important aspect of patient education: addressing eye care misinformation. He shares several main points to keep in mind for (kindly and professionally) navigating these difficult conversations—especially when a patient insists thHighlights From MOD Live 2024 in Nashville
https://modernod.com/podcasts/the-mod-pod/highlights-from-mod-live-2024-in-nashville/36865/In this special episode of The MOD Pod, Cecelia Koetting, OD, FAAO, Dipl ABO, interviews a diverse group of attendees from MOD Live 2024. She speaks with program chairs, faculty, newcomers, and returning attendees, capturing a wide range of perspectives.Treatment Tactics for RCE
https://modernod.com/topics/corneaanterior-segment/eye-care-insiders-oct-video-2023/37331/Joseph J. Allen, OD, FAAO, Dipl ABO, reviews best practices for the treatment of recurrent corneal erosion (RCE). He discusses conditions that tend to co-occur with RCE, how to diagnose RCE, and strategies for management, along with insights on what treatments have worked well for his patients.Patients Do the Darndest Things …
https://modernod.com/videos/eye-care-insiders/patients-do-the-darndest-things/37340/Joseph J. Allen, OD, FAAO, Dipl ABO, shares a lighthearted top 10 list of things patients do that drive him crazy. Are you familiar with the chin tippers, dramatic photophobes, pull backers, and others that he mentions?Ryzumvi Rundown
https://modernod.com/videos/eye-care-insiders/eye-care-insiders-nov-2023-video/37334/Joseph J. Allen, OD, FAAO, Dipl ABO, spends this episode of Eye Care Insiders discussing phentolamine ophthalmic solution 0.75% (Ryzumvi, Ocuphire Pharma), explaining how it works, reviewing clinical trial findings, potential adverse events, how it could fit into your clinic, and more.Demodex Blepharitis Under the Microscope
https://modernod.com/videos/eye-care-insiders/eye-care-insiders-may-2023-video/37325/Joseph Allen, OD, FAAO, Dipl ABO, tackles management of Demodex blepharitis in this month’s episode of Eye Care Insiders. He reviews what causes it, how to identify the signs and symptoms, available treatments and off-label options, patient education, novel therapies in the pipeline, and more.